Stay updated on HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now presents the completed NCT02718066 study record for HBI-8000 in combination with nivolumab, including its design, participant criteria, study locations, outcomes, and record dates. It also includes study protocol and statistical analysis plan documents.
    Difference
    63%
    Check dated 2026-11-09T12:30:48.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-02T11:40:25.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition-related update and says that “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-26T11:12:58.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T11:56:07.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-12T14:19:18.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error instead of the study details, indicating restricted access to the record. This blocks viewing the study information on the NCT02718066 page.
    Difference
    21%
    Check dated 2026-09-21T20:05:15.000Z thumbnail image

Stay in the know with updates to HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial page.